Anti-snoring Devices Market

By Treatment Type;

Device Types - [Mandibular Advancement Devices (MAD), Tongue Stabilizing Devices (TSD), Continuous Positive Airway Pressure (CPAP) Devices and Other Device Types], Surgical Procedure - [Uvulopalatopharyngoplasty (UPPP), Somnoplasty, Pillar Procedure, Tonsillectomy, Radiofrequency Palatoplasty, and Other Surgical Procedures]

By Surgery Type;

Uvulopalatopharyngoplasty, Radiofrequency Ablation, Laser-Assisted Uvulopalatoplasty, and Others

By Distribution Channel;

Online Stores, Pharmacies, Specialty Clinics, and Others

By End-User;

Hospitals, Sleep Clinics, Home Care Settings, and Others

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn635831592 Published Date: August, 2025

Anti-Snoring Market Overview

Anti-Snoring Market (USD Million)

Anti-Snoring Market was valued at USD 1,734.07 million in the year 2024. The size of this market is expected to increase to USD 3,115.39 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 8.7%.


Anti-snoring Devices Market

*Market size in USD million

CAGR 8.7 %


Study Period2025 - 2031
Base Year2024
CAGR (%)8.7 %
Market Size (2024)USD 1,734.07 Million
Market Size (2031)USD 3,115.39 Million
Market ConcentrationMedium
Report Pages326
1,734.07
2024
3,115.39
2031

Major Players

  • Fisher & Paykel Healthcare Limited
  • Koninklijke Philips NV
  • Resmed
  • ASF Medical GmbH (Tomed GmbH)
  • Apnea Sciences

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Anti-snoring Devices Market

Fragmented - Highly competitive market without dominant players


The Anti-Snoring Market is expanding rapidly as snoring becomes a widespread health concern. Research shows that over 40% of adults suffer from snoring, with men more affected than women. This rising prevalence has created strong demand for effective solutions, from wearable devices to innovative therapies.

Health Implications Driving Demand
Snoring is more than a nighttime nuisance—it is often associated with serious health risks such as sleep apnea, cardiovascular issues, and obesity. Studies reveal that nearly 30% of frequent snorers face the possibility of developing obstructive sleep apnea, intensifying the urgency for treatment options. As awareness spreads, more individuals are turning to targeted solutions.

Innovation in Anti-Snoring Technologies
Technological progress is reshaping the market with advanced oral appliances, smart monitoring devices, and AI-driven wearables. Consumer surveys highlight that about 25% of individuals prefer smart devices offering real-time tracking, showing how technology is shaping modern sleep healthcare.

Preference for Non-Surgical Methods
Non-invasive options dominate the market as patients increasingly favor nasal dilators, positional aids, and oral appliances. These solutions show 60% higher compliance rates compared to surgical procedures, making them a more attractive choice for long-term use. Manufacturers are responding by enhancing comfort and effectiveness.

Lifestyle Changes and Market Expansion
Rising obesity, unhealthy lifestyles, and growing awareness of sleep health are major factors accelerating the adoption of anti-snoring products. Reports suggest that around 35% of consumers actively seek ways to improve sleep quality and minimize snoring, strengthening the market’s growth trajectory within the broader sleep wellness sector.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Treatment Type
    2. Market Snapshot, By Surgery Type;
    3. Market Snapshot, By Distribution Channel
    4. Market Snapshot, By End-User
    5. Market Snapshot, By Region
  4. Anti-Snoring Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Increasing Awareness
        2. Technological Advancements
        3. Growing Prevalence
      2. Restraints
        1. High Costs
        2. Low Compliance
        3. Limited Effectiveness
      3. Opportunities
        1. Emerging Markets
        2. Product Innovations
        3. Online Retail Expansion
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Compititive Rivalry
  5. Market Segmentation
    1. Anti-Snoring Market, By Treatment Type, 2021 - 2031 (USD Million)
      1. Device Types
        1. Mandibular Advancement Devices (MAD)
        2. Tongue Stabilizing Devices (TSD)
        3. Continuous Positive Airway Pressure (CPAP) Devices
        4. Other Device Types
      2. Surgical Procedure
        1. Uvulopalatopharyngoplasty (UPPP)
        2. Somnoplasty
        3. Pillar Procedure
        4. Tonsillectomy
        5. Radiofrequency Palatoplasty
        6. Other Surgical Procedures
    2. Anti-Snoring Market, By Surgery Type, 2021 - 2031 (USD Million)

      1. Uvulopalatopharyngoplasty

      2. Radiofrequency Ablation

      3. Laser-Assisted Uvulopalatoplasty

      4. Others

    3. Anti-Snoring Market, By Distribution Channel, 2021 - 2031 (USD Million)

      1. Online Stores

      2. Pharmacies

      3. Specialty Clinics

      4. Others

    4. Anti-Snoring Market, By End-User, 2021 - 2031 (USD Million)

      1. Hospitals

      2. Sleep Clinics

      3. Home Care Settings

      4. Others

    5. Anti-Snoring Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Fisher & Paykel Healthcare Limited
      2. Koninklijke Philips NV
      3. Resmed
      4. ASF Medical GmbH (Tomed GmbH)
      5. Apnea Sciences
  7. Analyst Views
  8. Future Outlook of the Market